The lncRNA, RP5‐833A20.1, was found to be involved in the regulation of atherosclerosis development and was associated with elevated miR‐382‐5p levels, and the inhibition of nuclear factor IA (NFIA) expression. The gene discussed is NFIA; the disease is atherosclerosis.